Last reviewed · How we verify

NCT03949205: BREAK001

Sedentary Behavior Breaks With Isometric Exercise in Cardiovascular Health Indicators

Completed NA Last updated 29 September 2021
What this trial tests

NA trial testing Leg Extension Isometric Training in Sedentary Behavior in 17 participants. Completed in 20 February 2021.

Timeline
13 May 2019
Primary endpoint
30 December 2020
20 February 2021

Quick facts

Lead sponsorUniversity of Nove de Julho
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment17
Start date13 May 2019
Primary completion30 December 2020
Estimated completion20 February 2021
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Nove de Julho

Who can join

18 and older, any sex, with Sedentary Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to analyze the chronic effects of sedentary behavior breaks using the leg extension isometric exercise in the cardiovascular health indicators of healthy adults exposed to prolonged time in the sitting position. The patients recruited will be randomized into two groups: leg extension isometric training (TIE) and control group (CG). The TIE group will perform 12 weeks of isometric training. The CG will be advised not to change their routine activities, especially diet and physical activities.In the pre and post-intervention periods cardiovascular measures will be obtained.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sedentary Behavior

Currently open trials in the same condition.

Other University of Nove de Julho trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03949205.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing